Showing results (251-260 of 3,179) with videos related to

Sort By:
Pageof 318
Molecular Cancer Research : MCR|January 17, 2009
Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastomaOlivier Ayrault, Frederique Zindy, Jerold Rehg, et al.
Molecular Cancer Research : MCR|January 17, 2009
Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaMichael G Gartside, Huaibin Chen, Omar A Ibrahimi, et al.
Molecular Cancer Research : MCR|January 17, 2009
Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cellsShuhui Lim, Amos C Hung, Alan G Porter
Molecular Cancer Research : MCR|January 17, 2009
Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancerJohn Lai, Stephen A Myers, Mitchell G Lawrence, et al.
Molecular Cancer Research : MCR|January 17, 2009
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growthAmina Zoubeidi, Joice Rocha, Fatima Z Zouanat, et al.
Molecular Cancer Research : MCR|June 18, 2009
Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cellsYing Liu, Jingna Wang, Min Wu, et al.
Molecular Cancer Research : MCR|June 18, 2009
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell linesDavid E Modrak, Evelyn Leon, David M Goldenberg, et al.
Molecular Cancer Research : MCR|July 2, 2009
Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cellsKazutaka Ushio, Tomio Hashimoto, Naomi Kitamura, et al.
Molecular Cancer Research : MCR|September 3, 2009
Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell deathJoo-Yun Byun, Min-Jung Kim, Chang-Hwan Yoon, et al.
Molecular Cancer Research : MCR|September 10, 2009
Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptorNobuyuki Ozaki, Masaki Ohmuraya, Masahiko Hirota, et al.
Pageof 318